Citadel Advisors
LONA

Citadel Advisors’s LeonaBio Inc LONA Stock Holding History

Citadel Advisors’s Portfolio LONA Stock Details LONA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-440
Closed -$1.25K – 12466
2025
Q1 		$1.25K Buy
440
+360
+450% +$1.59K ﹤0.01% 14155
2024
Q4 		$469 Sell
80
-6,720
-99% -$37.9K ﹤0.01% 14319
2024
Q3 		$30.3K Buy
6,800
+5,510
+427% +$129K ﹤0.01% 12427
2024
Q2 		$34.2K Buy
1,290
+740
+135% +$17.5K ﹤0.01% 12146
2024
Q1 		$15.1K Buy
550
+40
+8% +$1.27K ﹤0.01% 13207
2023
Q4 		$12.4K Sell
510
-470
-48% -$8.34K ﹤0.01% 12994
2023
Q3 		$19.8K Sell
980
-2,820
-74% -$72.2K ﹤0.01% 12638
2023
Q2 		$112K Sell
3,800
-280
-7% -$7.98K ﹤0.01% 10753
2023
Q1 		$102K Sell
4,080
-240
-6% -$7.73K ﹤0.01% 11234
2022
Q4 		$137K Buy
4,320
+160
+4% +$5.04K ﹤0.01% 10745
2022
Q3 		$124K Sell
4,160
-31,890
-88% -$1.1M ﹤0.01% 10903
2022
Q2 		$1.1M Buy
36,050
+17,130
+91% +$1.57M ﹤0.01% 6809
2022
Q1 		$2.55M Sell
18,920
-40
-0.2% -$4.22K ﹤0.01% 5547
2021
Q4 		$2.47M Buy
18,960
+11,810
+165% +$1.49M ﹤0.01% 5760
2021
Q3 		$671K Buy
7,150
+2,180
+44% +$222K ﹤0.01% 9171
2021
Q2 		$509K Buy
+4,970
New +$868K ﹤0.01% 10020

Other funds holding LONA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
SSC
Spruce Street Capital New York $510M AUM
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Citadel Advisors's LONA Position: Q2 2026 in Review

Citadel Advisors opened a new position in LeonaBio Inc (LONA) in Q2 2026: 10,001 shares worth $91.9K. The stake represents ﹤0.01% of the portfolio and ranks #12754 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in LONA as recently as Q3 2025.

Citadel Advisors first reported a position in LONA in Q3 2020 and has held it in 20 quarters since. The position peaked at $39.8M in Q4 2020. 44 funds tracked by Wall St. Rank hold LONA as of Q2 2026.

  • Citadel Advisors held 10,001 shares of LeonaBio Inc worth $91.9K as of Q2 2026.
  • LeonaBio Inc was a new Citadel Advisors position in Q2 2026.
  • LeonaBio Inc made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #12754 holding.
  • Citadel Advisors first reported a position in LeonaBio Inc in Q3 2020 and has held it in 20 quarters since.
  • Citadel Advisors's LeonaBio Inc position peaked at $39.8M in Q4 2020.
  • 44 funds tracked by Wall St. Rank held LeonaBio Inc as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.